M. Paciaroni Et Al. , "Benefits and Risks of Clopidogrel vs. Aspirin Monotherapy after Recent Ischemic Stroke: A Systematic Review and Meta-Analysis," CARDIOVASCULAR THERAPEUTICS , vol.2019, 2019
Paciaroni, M. Et Al. 2019. Benefits and Risks of Clopidogrel vs. Aspirin Monotherapy after Recent Ischemic Stroke: A Systematic Review and Meta-Analysis. CARDIOVASCULAR THERAPEUTICS , vol.2019 .
Paciaroni, M., İNCE, F. B., Hu, B., Jeng, J., KUTLUK, M. K., Liu, L., ... Lou, M.(2019). Benefits and Risks of Clopidogrel vs. Aspirin Monotherapy after Recent Ischemic Stroke: A Systematic Review and Meta-Analysis. CARDIOVASCULAR THERAPEUTICS , vol.2019.
Paciaroni, Maurizio Et Al. "Benefits and Risks of Clopidogrel vs. Aspirin Monotherapy after Recent Ischemic Stroke: A Systematic Review and Meta-Analysis," CARDIOVASCULAR THERAPEUTICS , vol.2019, 2019
Paciaroni, Maurizio Et Al. "Benefits and Risks of Clopidogrel vs. Aspirin Monotherapy after Recent Ischemic Stroke: A Systematic Review and Meta-Analysis." CARDIOVASCULAR THERAPEUTICS , vol.2019, 2019
Paciaroni, M. Et Al. (2019) . "Benefits and Risks of Clopidogrel vs. Aspirin Monotherapy after Recent Ischemic Stroke: A Systematic Review and Meta-Analysis." CARDIOVASCULAR THERAPEUTICS , vol.2019.
@article{article, author={Maurizio Paciaroni Et Al. }, title={Benefits and Risks of Clopidogrel vs. Aspirin Monotherapy after Recent Ischemic Stroke: A Systematic Review and Meta-Analysis}, journal={CARDIOVASCULAR THERAPEUTICS}, year=2019}